4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000040
Director sold 68,142 shares at an average $33.09 ($2,254,951)
- Director acquired 68,142 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schenkein David P · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-23 | Exercise or conversion : show line 1 in the form | +47,731 | $31.64 | $1,510,209 | 170,585 | D |
| 2024-02-23 | Sale : show line 2 in the form | −47,731 | $33.05 | $1,577,510 | 122,854 | D |
| 2024-02-26 | Exercise or conversion : show line 3 in the form | +20,411 | $31.64 | $645,804 | 143,265 | D |
| 2024-02-26 | Sale : show line 4 in the form | −20,411 | $33.19 | $677,441 | 122,854 | D |
| Open-market sales · 68,142 sh · avg $33.09 · $2,254,951 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-23 | Exercise or conversion : show line 5 in the form Stock option (right to buy) | −47,731 | 89,740 | D |
| 2024-02-26 | Exercise or conversion : show line 6 in the form Stock option (right to buy) | −20,411 | 69,329 | D |
Loading xslF345X05/wk-form4_1709067874.xml…